| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/AJCN/54.3.548 |
| P953 | full work available at URL | http://academic.oup.com/ajcn/article-pdf/54/3/548/24064576/548.pdf |
| P698 | PubMed publication ID | 1652198 |
| P2093 | author name string | J. M. Bengoa | |
| M. D. Sitrin | |||
| M. J. Bolt | |||
| G. A. Leichtmann | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| cholecalciferol | Q139347 | ||
| P304 | page(s) | 548-552 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | American Journal of Clinical Nutrition | Q7713500 |
| P1476 | title | Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection | |
| P478 | volume | 54 |
| Q35557588 | Absorption of calcium and magnesium in patients with intestinal resections treated with medium chain fatty acids |
| Q85856580 | An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease |
| Q43478544 | Bone mineral density in Iranian patients with inflammatory bowel disease |
| Q35546413 | Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation? |
| Q42406756 | Endocrine and metabolic manifestations in inflammatory bowel disease |
| Q33572653 | Impact of vitamin D on the hospitalization rate of Crohn's disease patients seen at a tertiary care center |
| Q26998249 | Management of endocrine disease: Secondary osteoporosis: pathophysiology and management |
| Q42406589 | Manipulating bone disease in inflammatory bowel disease patients |
| Q35596697 | Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density |
| Q38286526 | Optimal vitamin D levels in Crohn's disease: a review |
| Q91856399 | Perspective on skeletal health in inflammatory bowel disease |
| Q35895555 | Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults |
| Q50456843 | Postprandial lipid and insulin responses among healthy, overweight men to mixed meals served with baked herring, pickled herring or baked, minced beef. |
| Q38712707 | Prevalence and risk factors for low bone mineral density in ulcerative colitis |
| Q37413426 | Review article: vitamin D and inflammatory bowel diseases |
| Q42547781 | Skin content of 7-dehydrocholesterol in patients with malabsorption |
| Q37081575 | The Role of Vitamin D in Inflammatory Bowel Disease |
| Q22242626 | The aetiology and impact of malnutrition in paediatric inflammatory bowel disease |
| Q33756525 | Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes: a case series |
| Q41253661 | Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission |
| Q33874475 | Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis |
| Q57284251 | Vitamin D deficiency is associated with disease activity in patients with Crohn's disease |
| Q35595579 | Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection |
| Q35492283 | Vitamin D status in children and young adults with inflammatory bowel disease |
| Q34238922 | Vitamin D status of infants in northeastern rural Bangladesh: preliminary observations and a review of potential determinants. |
Search more.